Close

ExeGi Pharma receives National Animal Supplement Council Quality Seal; company's commitment to quality standards in animal health supplements earns certification after rigorous audit

Mar 20, 2025 Press Release 2 min read

Exclusive Industry Insights

By submitting, you agree to our Privacy Policy

Share this article:

March 20, 2025 (press release) –

Listen to this article

ExeGi Pharma, a biotechnology company specializing in probiotics for humans and pets, has been awarded the National Animal Supplement Council (NASC) Quality Seal, a designation that recognizes the company’s commitment to the highest standards of quality and regulatory compliance in the animal health supplement industry.

The NASC Quality Seal is reserved for companies that meet rigorous standards for product quality, including adherence to strict labeling guidelines, comprehensive quality control protocols, adverse event monitoring and independent product testing. As part of the certification process, ExeGi Pharma underwent a thorough audit to verify compliance with NASC’s stringent requirements, reinforcing the company’s dedication to transparency and consumer trust.

“Receiving the NASC Quality Seal is an important milestone for ExeGi Pharma and a reflection of our ongoing commitment to excellence in animal health,” said Marc Tewey, CEO of ExeGi Pharma. “We take great pride in ensuring our products meet the highest safety and quality standards, giving veterinarians and pet owners confidence in our formulations.”

The NASC Quality Seal will now appear on ExeGi Pharma’s animal health products, signifying that they have met the organization’s rigorous benchmarks for manufacturing and quality assurance. This achievement aligns with ExeGi Pharma’s mission to deliver scientifically backed, high-quality probiotics that support the health and well-being of companion animals.

Visbiome Vet is a high potency probiotic for use in companion pets to help support normal inflammatory responses in the gastrointestinal tract (GI tract) and to help normalize gut health. The formulation in Visbiome Vet contains an eight-strain proprietary probiotic blend that has recently been studied in several canine GI concerns.

ExeGi Pharma, the maker of Visbione Vet, is a biotechnology company specializing in the development and commercialization of live biotherapeutic drugs for humans and probiotic agents for both humans and pets. With a strong foundation in microbiome science, ExeGi delivers innovative, clinically supported products designed to address a range of health needs. The company is headquartered in Rockville, Maryland.

 

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistribute or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

Stay Ahead of Changes

Don't Wait. Stay Informed.

The world and your industry are changing too fast. You need to know what's happening, and our Legislation Monitor can help. It's a critical resource for anyone who wants to stay ahead of regulatory and legal challenges. Then, discover the other ways that Industry Intelligence Inc. can help your business.

Cookie Preferences

This website uses cookies to enhance your browsing experience, analyze site performance, and deliver personalized content. We use a minimal cookie to remember your preferences. For detailed information about our cookie usage, please review our Privacy Policy.